These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1168 related items for PubMed ID: 12401843

  • 21. Fractional excretion of IgG predicts renal outcome and response to therapy in primary focal segmental glomerulosclerosis: a pilot study.
    Bazzi C, Petrini C, Rizza V, Napodano P, Paparella M, Arrigo G, Pisano L, D'Amico G.
    Am J Kidney Dis; 2003 Feb; 41(2):328-35. PubMed ID: 12552493
    [Abstract] [Full Text] [Related]

  • 22. Urinary N-acetyl-beta-D-glucosaminidase and beta 2-microglobulin excretion in primary nephrotic children.
    Calişkan S, Hacibekiroğlu M, Sever L, Ozbay G, Arisoy N.
    Nephron; 1996 Feb; 74(2):401-4. PubMed ID: 8893163
    [Abstract] [Full Text] [Related]

  • 23. Etiology of increased enzymuria in different morphological forms of glomerulonephritis.
    Kuźniar J, Marchewka Z, Lembas-Bogaczyk J, Kuźniar TJ, Klinger M.
    Nephron Physiol; 2004 Feb; 98(1):p8-14. PubMed ID: 15503426
    [Abstract] [Full Text] [Related]

  • 24. The differential diagnostic value of urinary enzyme and amino acid excretion in children with nephrotic syndrome.
    Panchenko EL, Chesney RW, Roy S, Budreau AM, Boehm KA.
    Pediatr Nephrol; 1994 Apr; 8(2):142-7. PubMed ID: 7912541
    [Abstract] [Full Text] [Related]

  • 25. Fractional excretion of high- and low-molecular weight proteins and outcome in primary focal segmental glomerulosclerosis.
    Deegens JK, Wetzels JF.
    Clin Nephrol; 2007 Oct; 68(4):201-8. PubMed ID: 17969486
    [Abstract] [Full Text] [Related]

  • 26. The excretion of N-acetyl-beta-glucosaminidase in glomerulonephritis.
    Hultberg B, Ravnskov U.
    Clin Nephrol; 1981 Jan; 15(1):33-8. PubMed ID: 7214750
    [Abstract] [Full Text] [Related]

  • 27. Low molecular weight proteinuria in human immunodeficiency virus-infected patients.
    Kabanda A, Vandercam B, Bernard A, Lauwerys R, van Ypersele de Strihou C.
    Am J Kidney Dis; 1996 Jun; 27(6):803-8. PubMed ID: 8651244
    [Abstract] [Full Text] [Related]

  • 28. The effect on proteinuria and urinary NAG of treatment with meloxicam in chronic glomerular disease patients--a preliminary study.
    Gluhovschi G, Velciov S, Kaycsa A, Trandafirescu V, Petrica L, Bozdog G, Gluhovschi C, Bob F, Vernic C.
    Int J Clin Pharmacol Ther; 2009 Jul; 47(7):444-53. PubMed ID: 19640351
    [Abstract] [Full Text] [Related]

  • 29. Vascular hyperpermeability in nephrotic edema.
    Rostoker G, Behar A, Lagrue G.
    Nephron; 2000 Jul; 85(3):194-200. PubMed ID: 10867533
    [Abstract] [Full Text] [Related]

  • 30. Effects of pentoxifylline administration on urinary N-acetyl-beta-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized study.
    Navarro JF, Mora C, Muros M, Maca M, Garca J.
    Am J Kidney Dis; 2003 Aug; 42(2):264-70. PubMed ID: 12900807
    [Abstract] [Full Text] [Related]

  • 31. Further evidence for tubular dysfunction in insulin dependent diabetes.
    Ratzmann KP, Schimke E, Jung K, Pergande M.
    J Diabet Complications; 1989 Aug; 3(3):167-71. PubMed ID: 2528561
    [Abstract] [Full Text] [Related]

  • 32. N-acetyl-beta-D-glucosaminidase and beta2-microglobulin: prognostic markers in idiopathic nephrotic syndrome.
    Fede C, Conti G, Chimenz R, Ricca M.
    J Nephrol; 1999 Aug; 12(1):51-5. PubMed ID: 10203005
    [Abstract] [Full Text] [Related]

  • 33. N-acetyl-beta-glucosaminidase and beta 2-microglobulin. Their urinary excretion in patients with renal parenchymal disease.
    Sherman RL, Drayer DE, Leyland-Jones BR, Reidenberg MM.
    Arch Intern Med; 1983 Jun; 143(6):1183-5. PubMed ID: 6190447
    [Abstract] [Full Text] [Related]

  • 34. Urinary N-acetyl-beta-glucosaminidase in children with idiopathic nephrotic syndrome.
    Tsau YK, Chen CH, Yang LF, Sheu JN.
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1991 Jun; 32(5):286-90. PubMed ID: 1776457
    [Abstract] [Full Text] [Related]

  • 35. [The role of tubulointerstitial changes in progression of kidney function failure in patients with chronic glomerulonephritis (GN)].
    Idasiak-Piechocka I, Krzymański M.
    Przegl Lek; 1996 Jun; 53(5):443-53. PubMed ID: 8754411
    [Abstract] [Full Text] [Related]

  • 36. Urinary excretion of type IV collagen and laminin in the evaluation of nephropathy in NIDDM: comparison with urinary albumin and markers of tubular dysfunction and/or damage.
    Banu N, Hara H, Okamura M, Egusa G, Yamakido M.
    Diabetes Res Clin Pract; 1995 Jul; 29(1):57-67. PubMed ID: 8593760
    [Abstract] [Full Text] [Related]

  • 37. T helper (Th)-cytokines in the urine of patients with primary glomerulonephritis treated with immunosuppressive drugs: Can they predict outcome?
    Kalavrizioti D, Gerolymos M, Rodi M, Kalliakmani P, Provatopoulou S, Eleftheriadis T, Mouzaki A, Goumenos DS.
    Cytokine; 2015 Dec; 76(2):260-269. PubMed ID: 26307557
    [Abstract] [Full Text] [Related]

  • 38. Urinary soluble HLA class I antigen in patients with minimal change disease: a predictor of steroid response.
    Park CW, Song HC, Shin YS, Ahn SJ, Kim YS, Kim SY, Choi EJ, Chang YS, Bang BK.
    Nephron; 1998 Dec; 79(1):44-9. PubMed ID: 9609461
    [Abstract] [Full Text] [Related]

  • 39. Urinary protein markers predict the severity of renal histological lesions in children with mesangial proliferative glomerulonephritis.
    Li Y, Wang J, Zhu X, Feng Q, Li X, Feng X.
    BMC Nephrol; 2012 May 20; 13():29. PubMed ID: 22607047
    [Abstract] [Full Text] [Related]

  • 40. The elevated levels of urinary angiotensinogen are correlated with the severity of idiopathic membranous nephropathy.
    Tang Z, Wang Y, Tao L, Guo Y, Zheng Y, Zheng D.
    BMC Nephrol; 2018 Dec 12; 19(1):357. PubMed ID: 30541470
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 59.